Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting
暂无分享,去创建一个
Stefano Bonini | Gerd Geerling | Christophe Baudouin | Pasquale Aragona | Maurizio Rolando | Marc Labetoulle | M. Irkec | M. Labetoulle | S. Bonini | C. Baudouin | M. Lemp | P. Aragona | Elisabeth M. Messmer | E. Messmer | G. Geerling | Murat Irkeç | G. V. van Setten | J. Benitez-Del-Castillo | José M. Benítez‐del‐Castillo | Francisco C. Figueiredo | Michael Lemp | Gysbert Van Setten | M. Rolando | F. Figueiredo | J. Benítez-del-Castillo
[1] K. Tsubota,et al. IL-6 induction in desiccated corneal epithelium in vitro and in vivo , 2011, Molecular vision.
[2] A. Solomon,et al. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. , 2001, Investigative ophthalmology & visual science.
[3] De-Quan Li,et al. Hyperosmolar Saline Is a Proinflammatory Stress on the Mouse Ocular Surface , 2005, Eye & contact lens.
[4] Friedrich Paulsen,et al. Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007). , 2007, The ocular surface.
[5] S. Lane,et al. Effect of Oral Re-esterified Omega-3 Nutritional Supplementation on Dry Eyes , 2016, Cornea.
[6] M. Labetoulle,et al. Impairment of lacrimal secretion in the unaffected fellow eye of patients with recurrent unilateral herpetic keratitis. , 2013, Ophthalmology.
[7] Christophe Baudouin,et al. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). , 2007, The ocular surface.
[8] K. Yoon,et al. Expression of Th-1 chemokines and chemokine receptors on the ocular surface of C57BL/6 mice: effects of desiccating stress. , 2007, Investigative ophthalmology & visual science.
[9] W. Feuer,et al. Interleukin-6 Levels in the Conjunctival Epithelium of Patients with Dry Eye Disease Treated with Cyclosporine Ophthalmic Emulsion , 2000, Cornea.
[10] Gerd Geerling,et al. An objective approach to dry eye disease severity. , 2010, Investigative ophthalmology & visual science.
[11] M. Irkec,et al. Diagnosing the severity of dry eye: a clear and practical algorithm , 2014, British Journal of Ophthalmology.
[12] C. Baudouin,et al. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. , 2001, Investigative ophthalmology & visual science.
[13] A. Roszkowska,et al. Safety and Efficacy of 0.1% Clobetasone Butyrate Eyedrops in the Treatment of Dry Eye in Sjögren Syndrome , 2013, European journal of ophthalmology.
[14] Chiara Barberi,et al. Natural killer cells in the innate immunity network of atherosclerosis. , 2015, Immunology letters.
[15] Algis J Vingrys,et al. A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease. , 2017, Ophthalmology.
[16] M. C. Acosta,et al. Decreased corneal sensitivity in patients with dry eye. , 2005, Investigative ophthalmology & visual science.
[17] De-Quan Li,et al. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. , 2006, Experimental eye research.
[18] C. Baudouin,et al. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. , 2000, Investigative ophthalmology & visual science.
[19] S. Pflugfelder,et al. Transforming growth factor beta-1 and beta-2 in human tear fluid. , 1996, Current eye research.
[20] Marisa Meloni,et al. Molecular mechanism of ocular surface damage: Application to an in vitro dry eye model on human corneal epithelium , 2011, Molecular vision.
[21] De-Quan Li,et al. IL-17 disrupts corneal barrier following desiccating stress , 2009, Mucosal Immunology.
[22] De-Quan Li,et al. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. , 2007, Investigative ophthalmology & visual science.
[23] C. McMonnies,et al. Conjunctival hyperaemia in non‐contact lens wearers , 1991, Acta ophthalmologica.
[24] De-Quan Li,et al. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. , 2004, Investigative ophthalmology & visual science.
[25] S. Yeh,et al. Apoptosis of ocular surface cells in experimentally induced dry eye. , 2003, Investigative ophthalmology & visual science.
[26] C. Murphy,et al. The pharmacologic assessment of a novel lymphocyte function-associated antigen-1 antagonist (SAR 1118) for the treatment of keratoconjunctivitis sicca in dogs. , 2011, Investigative ophthalmology & visual science.
[27] C. Creuzot-Garcher,et al. A multicentre, double‐masked, randomized, controlled trial assessing the effect of oral supplementation of omega‐3 and omega‐6 fatty acids on a conjunctival inflammatory marker in dry eye patients , 2011, Acta ophthalmologica.
[28] P. Gastaud,et al. Immunopathological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens. , 1992, The British journal of ophthalmology.
[29] Pasquale Aragona,et al. Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease. , 2015, Ophthalmology.
[30] De-Quan Li,et al. Epithelial-immune cell interaction in dry eye. , 2008, Cornea.
[31] K. Tsubota,et al. Functional lacrimal gland regeneration by transplantation of a bioengineered organ germ , 2013, Nature Communications.
[32] J. Chodosh,et al. Oral Tetracyclines for Ocular Rosacea: An Evidence-Based Review of the Literature , 2004, Cornea.
[33] Su-Ho Lim,et al. Clinical Applications of Anterior Segment Optical Coherence Tomography , 2015, Journal of ophthalmology.
[34] F. Mantelli,et al. Neurogenic inflammation of the ocular surface , 2010, Current opinion in allergy and clinical immunology.
[35] M. Musumeci,et al. Chitinase Levels in the Tears of Subjects With Ocular Allergies , 2008, Cornea.
[36] Kathryn S. Kennedy,et al. A phase 2 randomized, double-masked, placebo-controlled study of a novel integrin antagonist (SAR 1118) for the treatment of dry eye. , 2012, American journal of ophthalmology.
[37] Limitations of an ocular surface inflammatory biomarker in impression cytology specimens , 2013, Cutaneous and ocular toxicology.
[38] R. Dana,et al. Corneal Nerve Alterations in Dry Eye-associated Ocular Surface Disease , 2009, International ophthalmology clinics.
[39] Jian-ping Gao,et al. Desiccating Stress Induces T Cell-Mediated Sjögren’s Syndrome-Like Lacrimal Keratoconjunctivitis1 , 2006, The Journal of Immunology.
[40] Murat Dogru,et al. Application of visante optical coherence tomography tear meniscus height measurement in the diagnosis of dry eye disease. , 2010, Ophthalmology.
[41] S. Pflugfelder,et al. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome. , 1999, Ophthalmology.
[42] Tsutomu Takeuchi,et al. Conjunctival Epithelium Expression of HLA-DR in Dry Eye Patients , 1998, Ophthalmologica.
[43] Kyoung Yul Seo,et al. Multi-layered culture of primary human conjunctival epithelial cells producing MUC5AC. , 2007, Experimental eye research.
[44] Carolyn G. Begley,et al. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). , 2007, The ocular surface.
[45] A. Lambiase,et al. In Vivo Characterization of Doxycycline Effects on Tear Metalloproteinases in Patients with Chronic Blepharitis , 2009, European journal of ophthalmology.
[46] Zuguo Liu,et al. A mouse dry eye model induced by topical administration of benzalkonium chloride , 2011, Molecular vision.
[47] G. Ravera,et al. Systemic Linoleic and &ggr;-Linolenic Acid Therapy in Dry Eye Syndrome With an Inflammatory Component , 2003, Cornea.
[48] De-Quan Li,et al. JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells. , 2006, Experimental eye research.
[49] P. Aragona,et al. Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients. , 2005, Investigative ophthalmology & visual science.
[50] A. Tomlinson,et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. , 2013, The ocular surface.
[51] De-Quan Li,et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. , 2009, Investigative ophthalmology & visual science.
[52] De-Quan Li,et al. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. , 2004, Investigative ophthalmology & visual science.
[53] S. Pflugfelder,et al. Rationale for anti-inflammatory therapy in dry eye syndrome. , 2008, Arquivos brasileiros de oftalmologia.
[54] A. Vingrys,et al. Tear Interferon-Gamma as a Biomarker for Evaporative Dry Eye Disease. , 2016, Investigative ophthalmology & visual science.
[55] H. Zhan,et al. The immunomodulatory role of human conjunctival epithelial cells. , 2003, Investigative ophthalmology & visual science.
[56] M. Dana,et al. Animal models of dry eye: a critical assessment of opportunities and limitations. , 2004, Investigative ophthalmology & visual science.
[57] Gerd Geerling,et al. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). , 2007, The ocular surface.
[58] R. Dana,et al. Characterization of effector T cells in dry eye disease. , 2009, Investigative ophthalmology & visual science.
[59] Lei Zhou,et al. In-depth analysis of the human tear proteome. , 2012, Journal of proteomics.
[60] E. Messmer. The pathophysiology, diagnosis, and treatment of dry eye disease. , 2015, Deutsches Arzteblatt international.
[61] M. Calonge,et al. Dry Eye Disease as an Inflammatory Disorder , 2010, Ocular immunology and inflammation.
[62] M. Chang,et al. The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. , 2005, Korean journal of ophthalmology : KJO.
[63] De-Quan Li,et al. Hyperosmolarity-Induced Apoptosis in Human Corneal Epithelial Cells Is Mediated by Cytochrome c and MAPK Pathways , 2007, Cornea.
[64] P. Asbell,et al. HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease. , 2013, Experimental eye research.
[65] J. Etxebarria,et al. Tear proteome and protein network analyses reveal a novel pentamarker panel for tear film characterization in dry eye and meibomian gland dysfunction. , 2013, Journal of proteomics.
[66] L. Sobrin,et al. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant. , 2000, Investigative ophthalmology & visual science.
[67] P. Asbell,et al. The Core Mechanism of Dry Eye Disease Is Inflammation , 2014, Eye & contact lens.
[68] S. Pflugfelder,et al. Effects of Sequential Artificial Tear and Cyclosporine Emulsion Therapy on Conjunctival Goblet Cell Density and Transforming Growth Factor-β2 Production , 2008, Cornea.
[69] L. Wheeler,et al. Mitochondrial permeability transition pore in inflammatory apoptosis of human conjunctival epithelial cells and T cells: effect of cyclosporin A. , 2013, Investigative ophthalmology & visual science.
[70] M. Mingari,et al. Immune response in the conjunctival epithelium of patients with dry eye. , 2010, Experimental eye research.
[71] M. Calonge,et al. Cytokines and chemokines in immune-based ocular surface inflammation , 2008, Expert review of clinical immunology.
[72] M. Meloni,et al. Efficacy of a New Ocular Surface Modulator in Restoring Epithelial Changes in an In Vitro Model of Dry Eye Syndrome , 2017, Current eye research.
[73] Jian-ping Gao,et al. In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation. , 2008, Investigative ophthalmology & visual science.
[74] De-Quan Li,et al. Strain-Related Cytokine Profiles on the Murine Ocular Surface in Response to Desiccating Stress , 2007, Cornea.
[75] Pedram Hamrah,et al. In Vivo Confocal Microscopy of the Ocular Surface: From Bench to Bedside , 2014, Current eye research.
[76] S. Pflugfelder,et al. Tear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture. , 2011, American journal of ophthalmology.
[77] C. Lema,et al. Dry eye modulates the expression of toll-like receptors on the ocular surface. , 2015, Experimental eye research.
[78] E. Campos,et al. Hyperosmolar stress upregulates HLA-DR expression in human conjunctival epithelium in dry eye patients and in vitro models. , 2011, Investigative ophthalmology & visual science.
[79] M. Musumeci,et al. Acidic Mammalian Chitinase in Dry Eye Conditions , 2009, Cornea.
[80] S. Barabino,et al. Distribution of Conjunctival HLA-DR Expression and the Pathogenesis of Damage in Early Dry Eyes , 2005, Cornea.
[81] S. Joachim,et al. Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non–Dry Eye Patients , 2015, Cornea.
[82] C. Schaumburg,et al. Dry Eye as a Mucosal Autoimmune Disease , 2013, International reviews of immunology.
[83] D. Thompson,et al. Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. , 2002, Investigative ophthalmology & visual science.
[84] J. Anaya,et al. Gene expression and chromosomal location for susceptibility to Sjögren's syndrome. , 2009, Journal of autoimmunity.
[85] A. Lambiase,et al. Nerve growth factor therapy for corneal disease , 2012, Current opinion in ophthalmology.
[86] M. Dana,et al. The controlled-environment chamber: a new mouse model of dry eye. , 2005, Investigative ophthalmology & visual science.
[87] C. Joo,et al. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. , 2012, Investigative ophthalmology & visual science.
[88] H. Kim,et al. JNK and ERK MAP kinases mediate induction of IL-1β, TNF-α and IL-8 following hyperosmolar stress in human limbal epithelial cells , 2006 .
[89] L. Wheeler,et al. Ocular Surface APCs Are Necessary for Autoreactive T Cell-Mediated Experimental Autoimmune Lacrimal Keratoconjunctivitis , 2011, The Journal of Immunology.
[90] C. Baudouin,et al. Cytofluorimétrie sur empreintes conjonctivales au cours de la kératoconjonctivite sèche: effets de la ciclosporine topique sur l'expression d'antigène HLA DR , 2003 .
[91] J. Elisseeff,et al. Biomaterials and Tissue Engineering Strategies for Conjunctival Reconstruction and Dry Eye Treatment , 2015, Middle East African journal of ophthalmology.
[92] F. Mantelli,et al. In-vivo confocal microscopy of the ocular surface: ocular allergy and dry eye , 2013, Current opinion in allergy and clinical immunology.
[93] S. Tauber,et al. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. , 2013, JAMA ophthalmology.
[94] C. Creuzot-Garcher,et al. Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca. , 2000, Ophthalmology.
[95] R. Dana,et al. Pathways of corneal and ocular surface inflammation: a perspective from the cullen symposium. , 2005, The ocular surface.
[96] S. Pflugfelder. Antiinflammatory therapy for dry eye. , 2004, American journal of ophthalmology.
[97] Hyun Soo Lee,et al. Extraorbital Lacrimal Gland Excision: A Reproducible Model of Severe Aqueous Tear-Deficient Dry Eye Disease , 2014, Cornea.
[98] R. Dana,et al. Dry eye disease: an immune-mediated ocular surface disorder. , 2012, Archives of ophthalmology.
[99] I. Gipson,et al. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. , 2002, Archives of ophthalmology.
[100] Frank Eperjesi,et al. Essential fatty acids for dry eye: A review. , 2010, Contact lens & anterior eye : the journal of the British Contact Lens Association.
[101] De-Quan Li,et al. A mouse model of keratoconjunctivitis sicca. , 2002, Investigative ophthalmology & visual science.
[102] I. Gipson,et al. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. , 2000, Archives of ophthalmology.
[103] J. Garrigue,et al. Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease: A Multicenter Randomized Trial , 2016, European journal of ophthalmology.
[104] Shruti Aggarwal,et al. Image-guided evaluation and monitoring of treatment response in patients with dry eye disease , 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.
[105] P. Aragona. Topical cyclosporine: are all indications justified? , 2014, British Journal of Ophthalmology.
[106] D. Ward,et al. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops. , 1989, Archives of ophthalmology.
[107] M. Labetoulle,et al. Evidence of seasonality and effects of psychrometry in dry eye disease , 2016, Acta ophthalmologica.
[108] M. Dana,et al. Dry eye syndromes. , 2007, Chemical immunology and allergy.
[109] A. Yağcı,et al. The role and treatment of inflammation in dry eye disease , 2014, International Ophthalmology.
[110] C. Baudouin,et al. Flow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflammation. , 1997, Investigative ophthalmology & visual science.
[111] K. Gumus,et al. The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca , 2008, Clinical ophthalmology.